Stay updated on Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page
- Check4 days agoChange DetectedAdded the term Malignant fibrous histiocytoma to related terms and added Genetic and Rare Diseases Information Center as a resources reference.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to core study details or user-facing content.SummaryDifference0.0%

- Check25 days agoChange DetectedPage revision updated to v3.4.3 (March 2026); prior revision details (v3.4.2) and September 2025 entries were removed.SummaryDifference0.3%

- Check54 days agoChange DetectedRevision: v3.4.2 added; the notice about government funding lapse and operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedSite-wide notice about a lapse in government funding and an update to the page revision (v3.4.1), replacing the previous v3.4.0 reference.SummaryDifference0.4%

- Check68 days agoChange DetectedShow glossary toggle was added to the page and new metadata fields Last Update Submitted that Met QC Criteria and Last Update Posted were introduced. Minor wording changes were made to No FEAR Act data and the revision note (Revision: v3.4.0).SummaryDifference0.2%

Stay in the know with updates to Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.